<SEC-DOCUMENT>0001437749-24-006005.txt : 20240229
<SEC-HEADER>0001437749-24-006005.hdr.sgml : 20240229
<ACCEPTANCE-DATETIME>20240229101437
ACCESSION NUMBER:		0001437749-24-006005
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240220
FILED AS OF DATE:		20240229
DATE AS OF CHANGE:		20240229

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Hannasch Brian
		CENTRAL INDEX KEY:			0001911504
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41775
		FILM NUMBER:		24699655

	MAIL ADDRESS:	
		STREET 1:		123 FRONT STREET
		CITY:			MEMPHIS
		STATE:			TN
		ZIP:			38103

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neuraxis, INC
		CENTRAL INDEX KEY:			0001933567
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				455079684
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		11611 N. MERIDIAN ST
		STREET 2:		SUITE 330
		CITY:			CARMEL
		STATE:			IN
		ZIP:			46032
		BUSINESS PHONE:		(812) 689-0791

	MAIL ADDRESS:	
		STREET 1:		11611 N. MERIDIAN ST
		STREET 2:		SUITE 330
		CITY:			CARMEL
		STATE:			IN
		ZIP:			46032
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rdgdoc.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2024-02-20</periodOfReport>

    <issuer>
        <issuerCik>0001933567</issuerCik>
        <issuerName>Neuraxis, INC</issuerName>
        <issuerTradingSymbol>NRX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001911504</rptOwnerCik>
            <rptOwnerName>Hannasch Brian</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>8815 W. STATE ROAD 46</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>COLUMBUS</rptOwnerCity>
            <rptOwnerState>IN</rptOwnerState>
            <rptOwnerZipCode>47201</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isTenPercentOwner>1</isTenPercentOwner>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2024-02-20</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>75000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>757901</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">On February 20, 2024, the reporting person received 75,000 shares of common stock of Neuraxis, Inc. pursuant to the terms of a Consulting Agreement dated December 27, 2023.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Griffin D. Foster, Attorney-in-fact for Brian P. Hannasch</signatureName>
        <signatureDate>2024-02-29</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
